(EMAILWIRE.COM, July 27, 2018 ) According to the report Latin America RNAi Drug Delivery Market, published by Market Data Forecast, the market is projected to reach USD 10.25 billion by 2023, at a CAGR of 26% from 2018 to 2023.

RNA interference is a process in which RNA inhibits the gene expression, by degrading mRNA molecules. It is also called Gene silencing. It is one of the important methods to analyze gene functions. The process in which artificial drugs are sent with the intention of carrying out these functions is called RNAi drug delivery.

RNAi has various applications in therapeutics such as metabolic disorders, cardiology, oncology, ophthalmology and neurology. It also has applications in agriculture and research and development activities. RNAi can also be used to reduce the toxicity levels of gain-of-function proteins and trigger cytotoxicity within tumors.

Get a comprehensive overview of the Latin America RNAi Drug Delivery Market: http://www.marketdataforecast.com/market-reports/latin-america-rnai-drug-delivery-market-1980/

Latin America RNAi Drug Delivery Market: Drivers and Restraints
Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases and research studies conducted in therapeutics also increased the growth of RNAi drug delivery market in Latin America. Increases in innovative applications in the usage of drug delivery technology also play a major role in driving the market growth. Requirement of huge investments and strict regulatory framework are the major restraining factors of the market. Lack of availability of advanced technologies in Latin America region when compared to the developed countries provides many opportunities for the industries in this region.
Get accurate market forecast and analysis on the Latin America RNAi Drug Delivery Market.

Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/latin-america-rnai-drug-delivery-market-1980/request-sample

Latin America RNAi Drug Delivery Market: Segmentation
By Drug Delivery:
• Pulmonary drug delivery technology
• Aptamer drug delivery technology
• Nucleic acid drug delivery technology
• Nanoparticle drug delivery technology
By Therapeutic application:
• Cardiology
• metabolic disorders
• Oncology
• Ophthalmology
• Infectious diseases
• Neurology

From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at:

Latin America RNAi Drug Delivery Market: Overview
Ability of RNAi to block nucleotides to manipulate gene functions is useful in treating genetic disorders and chronic diseases. Extensive investment in research and development to study cancer therapeutics due to rise in cancer population led to the growth of this market. Introduction of new biomolecules that can target specific cell receptors to detect cancer is responsible for market growth. RNAi drug delivery is a new therapeutic method. Since only targeted cells or genes are modified, it has fewer side effects and is specific to the point. High investments and strict regulations are the restraining factors of this market. Delivering the drugs to the targeted nucleotides or genes is the key challenge faced by RNAi drug delivery market.

Latin America RNAi Drug Delivery Market: Regional Outlook
Latin America RNAi Drug Delivery market is geographically segmented into Brazil, Argentina, Mexico and other countries in South America. Increased investments by key players in this region are the major driving factor for the market. This market has the highest growth rate as evident from the CAGR.

Key Questions Answered
• What are the key, high growth markets that RNAi drug delivery market players should expand into? Which market segments are growing the fastest?
• What is the competitive landscape and market share of major players in the RNAi drug delivery market in Latin America?
• What are the challenges and restraints that have limiting the widespread adoption of RNAi drug delivery?
• What are the unmet needs with the RNAi drug delivery currently on the market? How will emerging technologies fulfill these unmet needs?
• What is healthcare professional perception and market outlook of RNAi drug delivery?

Latin America RNAi Drug Delivery Market: Key Players
Key players in this region are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Access Pharmaceuticals Inc., Sirnaomics Inc., Isis Pharmaceuticals Inc, RXi Pharmaceuticals Corp., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Marina Biotech Inc., Tacere Therapeutics Inc., and PhaseRx Inc.

Reasons to buy Latin America RNAi Drug Delivery Market Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Medical Devices Segment:
1. Cardiac Assist Devices Market: http://www.marketdataforecast.com/market-reports/global-cardiac-assist-devices-market-25/
2. Dental Consumable Market: http://www.marketdataforecast.com/market-reports/global-dental-consumables-market-42/
3. Wearable Medical Devices Market: http://www.marketdataforecast.com/market-reports/global-wearable-medical-devices-market-66/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results